These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 8140621)

  • 21. A beta A4 amyloid precursor protein gene and Alzheimer's disease.
    Hendriks L; Van Broeckhoven C
    Eur J Biochem; 1996 Apr; 237(1):6-15. PubMed ID: 8620894
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phosphorylation of FE65 Ser610 by serum- and glucocorticoid-induced kinase 1 modulates Alzheimer's disease amyloid precursor protein processing.
    Chow WN; Ngo JC; Li W; Chen YW; Tam KM; Chan HY; Miller CC; Lau KF
    Biochem J; 2015 Sep; 470(3):303-17. PubMed ID: 26188042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Alzheimer's dementia and amyloid precursor-protein].
    Blom N; Linnemann D
    Ugeskr Laeger; 1992 Apr; 154(15):1010-5. PubMed ID: 1566508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amyloid precursor protein (APP) and beta A4 amyloid in Alzheimer's disease and Down syndrome.
    Beyreuther K; Dyrks T; Hilbich C; Mönning U; König G; Multhaup G; Pollwein P; Masters CL
    Prog Clin Biol Res; 1992; 379():159-82. PubMed ID: 1409743
    [No Abstract]   [Full Text] [Related]  

  • 25. Predominant deposition of amyloid-beta 42(43) in plaques in cases of Alzheimer's disease and hereditary cerebral hemorrhage associated with mutations in the amyloid precursor protein gene.
    Mann DM; Iwatsubo T; Ihara Y; Cairns NJ; Lantos PL; Bogdanovic N; Lannfelt L; Winblad B; Maat-Schieman ML; Rossor MN
    Am J Pathol; 1996 Apr; 148(4):1257-66. PubMed ID: 8644866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of amyloid beta-protein in Alzheimer's disease.
    Regland B; Gottfries CG
    Lancet; 1992 Aug; 340(8817):467-9. PubMed ID: 1354793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Processing of the Alzheimer's disease beta A4 amyloid protein precursor (APP).
    Younkin SG
    Brain Pathol; 1991 Jul; 1(4):253-62. PubMed ID: 1669715
    [No Abstract]   [Full Text] [Related]  

  • 28. The phosphatidylinositol 3-kinase inhibitor wortmannin alters the metabolism of the Alzheimer's amyloid precursor protein.
    Petanceska SS; Gandy S
    J Neurochem; 1999 Dec; 73(6):2316-20. PubMed ID: 10582589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Processing of the pre-beta-amyloid protein by cathepsin D is enhanced by a familial Alzheimer's disease mutation.
    Dreyer RN; Bausch KM; Fracasso P; Hammond LJ; Wunderlich D; Wirak DO; Davis G; Brini CM; Buckholz TM; König G
    Eur J Biochem; 1994 Sep; 224(2):265-71. PubMed ID: 7523115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutations in APP and their role in beta-amyloid deposition.
    Fidani L; Goate A
    Prog Clin Biol Res; 1992; 379():195-214. PubMed ID: 1409745
    [No Abstract]   [Full Text] [Related]  

  • 31. Alzheimer's disease: a dysfunction of the amyloid precursor protein(1).
    Neve RL; McPhie DL; Chen Y
    Brain Res; 2000 Dec; 886(1-2):54-66. PubMed ID: 11119687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production.
    Citron M; Oltersdorf T; Haass C; McConlogue L; Hung AY; Seubert P; Vigo-Pelfrey C; Lieberburg I; Selkoe DJ
    Nature; 1992 Dec; 360(6405):672-4. PubMed ID: 1465129
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beta A4 amyloid protein and its precursor in Alzheimer's disease.
    Bush AI; Beyreuther K; Masters CL
    Pharmacol Ther; 1992; 56(1):97-117. PubMed ID: 1297146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alzheimer's disease: a central role for amyloid.
    Selkoe DJ
    J Neuropathol Exp Neurol; 1994 Sep; 53(5):438-47. PubMed ID: 8083687
    [No Abstract]   [Full Text] [Related]  

  • 35. A possible role for cathepsins D, E, and B in the processing of beta-amyloid precursor protein in Alzheimer's disease.
    Mackay EA; Ehrhard A; Moniatte M; Guenet C; Tardif C; Tarnus C; Sorokine O; Heintzelmann B; Nay C; Remy JM; Higaki J; Van Dorsselaer A; Wagner J; Danzin C; Mamont P
    Eur J Biochem; 1997 Mar; 244(2):414-25. PubMed ID: 9119007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The cytosolic domain of APP and its possible role in the pathogenesis of Alzheimer's disease.
    Minopoli G; Zambrano N; Russo T
    Ital J Biochem; 2006; 55(3-4):205-11. PubMed ID: 17274526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The proteins BACE1 and BACE2 and beta-secretase activity in normal and Alzheimer's disease brain.
    Stockley JH; O'Neill C
    Biochem Soc Trans; 2007 Jun; 35(Pt 3):574-6. PubMed ID: 17511655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypomethylation of the amyloid precursor protein gene in the brain of an Alzheimer's disease patient.
    West RL; Lee JM; Maroun LE
    J Mol Neurosci; 1995; 6(2):141-6. PubMed ID: 8746452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The triplet of lysine residues (Lys724-Lys725-Lys726) of Alzheimer's amyloid precursor protein plays an important role in membrane anchorage and processing.
    Usami M; Yamao-Harigaya W; Maruyama K
    J Neurochem; 1993 Jul; 61(1):239-46. PubMed ID: 8515269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid.
    Mullan M; Crawford F; Axelman K; Houlden H; Lilius L; Winblad B; Lannfelt L
    Nat Genet; 1992 Aug; 1(5):345-7. PubMed ID: 1302033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.